| 10.91 -0.05 (-0.46%) | 07-20 10:13 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.88 | 1-year : | 15.04 |
| Resists | First : | 11.02 | Second : | 12.88 |
| Pivot price | 10.44  |
|||
| Supports | First : | 10.05 | Second : | 9.44 |
| MAs | MA(5) : | 10.7 |
MA(20) : | 10.31 |
| MA(100) : | 10.83 |
MA(250) : | 10.1 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 92.1 |
D(3) : | 82.3 |
| RSI | RSI(14): 61.3 |
|||
| 52-week | High : | 13.43 | Low : | 8.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AHCO ] has closed below upper band by 12.7%. Bollinger Bands are 32.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.04 - 11.09 | 11.09 - 11.13 |
| Low: | 10.68 - 10.73 | 10.73 - 10.79 |
| Close: | 10.88 - 10.96 | 10.96 - 11.03 |
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Tue, 14 Jul 2026
AdaptHealth schedules Aug. 4 call on second-quarter results - Stock Titan
Tue, 07 Jul 2026
AdaptHealth (NASDAQ: AHCO) to redeem $325M 6.125% 2028 notes - Stock Titan
Mon, 06 Jul 2026
AdaptHealth (NASDAQ: AHCO) CCO sells 11,275 shares in 10b5-1 planned trade - Stock Titan
Wed, 24 Jun 2026
AdaptHealth (AHCO) Stock Trades Up, Here Is Why - Yahoo Finance
Wed, 06 May 2026
AdaptHealth (AHCO) Q1 2026 Earnings Transcript - The Motley Fool
Tue, 05 May 2026
AHCO Q1 Deep Dive: Capitated Growth Boosts Revenue, Margin Pressures Persist - StockStory
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 136 (M) |
| Shares Float | 86 (M) |
| Held by Insiders | 8.1 (%) |
| Held by Institutions | 106.7 (%) |
| Shares Short | 8,060 (K) |
| Shares Short P.Month | 7,540 (K) |
| EPS | -0.59 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.31 |
| Profit Margin | -2.5 % |
| Operating Margin | 0.6 % |
| Return on Assets (ttm) | 2.6 % |
| Return on Equity (ttm) | -4.9 % |
| Qtrly Rev. Growth | 5.4 % |
| Gross Profit (p.s.) | 4.92 |
| Sales Per Share | 24.18 |
| EBITDA (p.s.) | 4.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 600 (M) |
| Levered Free Cash Flow | 268 (M) |
| PE Ratio | -18.48 |
| PEG Ratio | 0 |
| Price to Book value | 0.96 |
| Price to Sales | 0.45 |
| Price to Cash Flow | 2.47 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|